Drugging the catalytically inactive state of RET kinase in RET-rearranged tumorsDennis Plenker, Martin L. Sos, M Riedel et al.|Science Translational Medicine|2017Cited by 64
Targeted degradation of CDK9 potently disrupts the MYC-regulated networkMohammed A. Toure, Angela N. Koehler, Florian Kabinger et al.|Cell chemical biology|2025Cited by 12